Professor Friend studied medicine at Cambridge University and St Thomas’s Hospital and, after qualifying, trained as a surgeon in London and Cambridge before undertaking a period of research at the University of Cambridge under the supervision of Professor Sir Roy Calne.

In 1988 he was appointed Visiting Assistant Professor of Surgery at Indiana University Medical Center, USA, where he was responsible for initiating a programme of liver transplantation.  He returned to the UK in 1989 to take up the post of University Lecturer (Honorary Consultant) in the University Department of Surgery at Cambridge. He was the Clinical Director of the Cambridge Transplant Unit and also a Fellow and Director of Studies in Medicine at Magdalene College, Cambridge. 

In 1999 he was appointed to the post of Professor of Transplantation at the University of Oxford and Consultant Transplant and Hepatobiliary Surgeon at the Oxford University Hospitals NHS Trust.  At that time he was also appointed Director of the Oxford Transplant Centre. 

Over the last two decades, the numbers and types of transplants carried out in Oxford have increased.  The Unit now undertakes, kidney, kidney and pancreas, pancreas alone, islet and intestinal transplants.  Oxford is the largest (in terms of numbers of transplants carried out each year) pancreas transplant unit in Europe.    

Peter's research interests lie primarily in novel applications of normothermic organ perfusion, ranging from organ preservation and repair prior to transplantation to its use for extracorporeal support in acute liver failure. He has published over 300 papers relating to clinical transplantation, immunosuppression, monoclonal antibodies, xenotransplantation, isolated organ perfusion, as well as various aspects of general surgery.

Peter is one of two academic founders of OrganOx and currently its Chief Medical Officer, with responsibilities that include the pre-clinical and clinical studies of OrganOx's normothermic organ perfusion technology.

He trained for six years as a nephrologist and transplant physician at the Western Infirmary in Glasgow. Subsequently he worked as a Consultant Nephrologist with a special interest in transplantation at the University Hospital of North Staffordshire. During this period he developed an interest in non-adherence in young adult transplant recipients and transition of care from paediatric to adult care. He established a joint transition process with Birmingham Children's Hospital.

In 2002, Dr Harden joined the Oxford Kidney Unit and Transplant Centre and has continued to pursue his interest in transition, having established joint clinics with Great Ormond Street and Evelina Children's Hospitals in London. He is clinical advisor to the National Health Service in the UK on adolescent transition and young adult services in patients with ESRD. He runs a unique community-based young adult transplant service in Oxford.

In addition Paul Harden is interested in malignancy post-transplantation and the impact of targeted immunosuppression reduction. He is Chief Investigator of the RESCUE (UK) trial of immunosuppression modulation for squamous cell skin cancer post-transplantation. He is currently working with a European consortium on development of a trial of cell therapy to allow immunosuppression reduction.

I undertook my undergraduate studies at Corpus Christi College, Cambridge, gaining a BA in medical science in 2000 before studying clinical medicine at Addenbrooke's Hospital, Cambridge. I qualified as a doctor in 2002, and moved to Nottingham for my Basic Surgical Training. I moved to Oxford in May 2006 to take up a position with the Centre for Evidence in Transplantation (CET) as a clinical research fellow in transplant surgery, during which time I completed my Master of Surgery (MChir) thesis with the University of Cambridge.
After completion of my surgical training, I took up a post as an Honorary Consultant Transplant Surgeon and Senior Clinical Research Fellow at Oxford in 2017. My clinical interests are in transplantation, living donation and vascular access surgery. I am the clinical lead for living kidney donation, and divisional medical informatics lead for SUWON division.
I have now taken over as Director of the CET. My research interests lie in evidence-based transplant surgery, transplant clinical trials and trial methodology. I have completed a large number systematic reviews relating to the optimisation of post-transplant immunosuppression and other topics in transplantation. I have also been involved in a number of investigator-led and industry funded international clinical trials, including the design of the Consortium for Organ Preservation in Europe (COPE) trials of novel organ preservation techniques, and am co-PI for a number of ongoing clinical trials in organ preservation including the DeFAT study and the PLUS study.

I am also currently working with the Oxford Computational Health Informatics lab (CHI), investigating the use of Artificial Intelligence in helping to make decisions about organ offers.

For more information on my work, and that of the CET, please visit the CET website. 

Consultant Transplant Nephrologist

Phil Mason qualified from Guy's Hospital in 1979 and after junior doctor posts mainly in London, he trained in nephrology and transplantation at Hammersmith Hospital. He undertook immunology research leading to a PhD following which he was appointed Clinical Lecturer and then Senior Lecturer and Honorary Consultant in 1994.  He moved to Oxford in 1995.

He has been the clinical lead for nephrology since 2009 and has a major interest in transplantation.  He established the antibody incompatible transplant programme in Oxford and is an investigator on several nephrology and transplant studies.  He sits on various national council related bodies including the NHSBT Kidney Advisory Group and the Living Donor Kidney Transplant 2020 Strategy Implementation Group.

Professor of Transplantation Biology and Honorary Consultant Transplant Surgeon, Nuffield Department of Surgical Sciences, University of Oxford, United Kingdom.

Professor of Transplant Surgery, University Medical Centre Groningen, The Netherlands.

Rutger J. Ploeg was born in The Hague in the Netherlands and educated at the University of Leiden. During his medical education he followed electives in Indonesia, Toronto and Cambridge. He was trained as a surgeon at the Leiden University Medical Centre. During his research fellowship in Madison at the University of Wisconsin with Dr. F.O. Belzer he became interested in organ donation, ischemia & reperfusion injury and preservation in transplantation. He was involved in the experimental studies and clinical introduction of the UW solution and received his PhD cum laude at the University of Leiden in 1991. After his clinical ASTS fellowship at the University of Wisconsin Hospital & Clinics, he was appointed consultant surgeon in 1994 at the University Medical Centre Groningen in the Netherlands and became a Professor of Surgery in 2001. He served the European Society for Organ Transplantation as Secretary and was elected President of ESOT in 2009.

Until May 2011 he was Head of the Division of Abdominal and Transplant Surgery in Groningen. In June 2011 he accepted a Chair at the University of Oxford in Transplantation Biology and works as Honorary Consultant Transplant Surgeon in the Oxford Transplant Centre. Recently he was appointed chair of the BRC Working Group Transplantation in Oxford and as National Clinical Lead for Organ Retrieval with NHSBT Blood and Transplant.

In the past decade Rutger Ploeg has intensively focused and published with his group on how the number and quality of donor organs and their viability can be improved.

He is currently coordinating a national consortium with NHSBT in the UK to investigate quality in Organ Donation and an international consortium in Europe to study preservation (EU7FW; COPE)

Miss Isabel Quiroga

Isabel is a consultant surgeon at the Oxford Transplant Centre and the Clinical Lead for organ retrieval. Within the COPE study, Isabel is involved as local coordinator of the COMPARE kidney study in the UK and is working closely with the COMPARE lead in Leuven (Belgium).

Srikanth Reddy was appointed as Consultant Hepatopancreaticobiliary and Transplant Surgeon at Oxford in 2010. He trained in Oxford and Birmingham. He did three years of research in Oxford and obtained a PhD in normothermic perfusion for organ preservation in liver transplantation. He is lead for Clinical Governance in the Transplant Division, where his role is to ensure safe clinical practice. His research interests include strategies to reduce ischaemia reperfusion injury in liver, pancreas and kidneys.

Consultant Nephrology and Transplant Medicine
Oxford Kidney Unit, Oxford University Hospitals

Dr Sharples was appointed as consultant in renal medicine in 2007, and works full-time in nephrology and transplant medicine. He is medical lead for the Oxford pancreas transplant programme, one of the largest in Europe. The programme is active in clinical research, with local and national collaborations. He is a member of Renal Registry Transplant Study group, Renal Medicine Specialist Advisory Committee and the Renal Associations guidelines committee. He acts on external reference groups for Kidney Research UK and NICE NHS Evidence.

Consultant Transplant Surgeon

Sanjay is the Lead for Living Donor surgery & Kidney Transplantation. His areas of expertise are in transplantation of Kidney, pancreas & small bowel, Laparoscopic Surgery including living donor surgery, Dialysis Access and General Surgery. After completing his surgical residency at the All India Institute of Medical Sciences, New Delhi, Sanjay trained in Liverpool & Oxford and obtained his Specialist Registration in 2005. Since then he has been associated with the Oxford Transplant Centre and has been integral in its transformation in to a major transplant centre in Europe.

Henk Giele

Henk Giele has been a consultant plastic, hand, and microsurgeon in Oxford at the Radcliffe Infirmary, John Radcliffe, Churchill and Nuffield Orthopaedic Centre (now merged to Oxford University Hospitals) since 1996. Although initially providing plastic surgery services for example treating skin cancers, he became seriously involved in the Oxford Transplant Centre in 2011 providing soft tissue cover following intestinal transplantation. This led to the development of abdominal wall transplantation (AWT) including novel innovations to reduce ischaemia reperfusion injury, or stand-alone AWT.
    
Other research interests are examining perfusion, preservation and manipulation of VCA with cellular therapies.